Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "CROs"

4243 News Found

Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
News | June 11, 2026

Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access

The Prayagraj lab is designed to handle both routine and specialised testing


DFE Pharma wins third straight EcoVadis Gold Medal
News | June 11, 2026

DFE Pharma wins third straight EcoVadis Gold Medal

The award places the company in the top 5% globally


Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities
Digitisation | June 11, 2026

Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions


Ten years on, PMSMA continues to shape safer motherhood in India
Policy | June 10, 2026

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines


AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities


Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


Ajanta Pharma elevates Atul Galgalikar as Vice President for international business
People | June 10, 2026

Ajanta Pharma elevates Atul Galgalikar as Vice President for international business

Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role